Noninvasive assessment of murine pulmonary arterial pressure validation and application to models of pulmonary hypertension

Circulation: Cardiovascular Imaging

Volumn 3, Issue 2, 2010, Pages 157-163

  Thibault, Hélène B ^a   Kurtz, Baptiste ^a   Raher, Michael J ^a   Shaik, Rahamthulla S ^a   Waxman, Aaron ^a   Derumeaux, Geneviève ^b   Halpern, Elkan F ^a   Bloch, Kenneth D ^a   Scherrer Crosbie, Marielle ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Echocardiography; Mice; Right ventricular systolic pressure

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; INTERLEUKIN 6;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOPPLER ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; HEART CATHETERIZATION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; LUNG ARTERY PRESSURE; MALE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; ECHOGRAPHY; IMAGE PROCESSING; METHODOLOGY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; TRANSGENIC MOUSE; VALIDATION STUDY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; HEART CATHETERIZATION; HYPERTENSION, PULMONARY; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PULMONARY ARTERY; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 77951908850     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.887109     Document Type: Article

References (27)

1. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004; 351: 1655-1665.
2. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the Task Force on Diagnosis and Treatment of Pulmo-nary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004; 25: 2243-2278.
3. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004; 351: 1425-1436.
4. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009; 104: 236-244.
5. Song Y, Coleman L, Shi J, Beppu H, Sato K, Walsh K, Loscalzo J, Zhang YY. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice. Am J Physiol Heart Circ Physiol. 2008; 295: H677-H690.
6. Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, Kihara S, Bloch KD, Libby P, Luster AD. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol. 2009; 41: 397-406.
7. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Moliterno DJ, Mukherjee D, Pohost GM, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc, and the Pulmonary Hypertension Association. Circulation. 2009; 119: 2250-2294.
8. Jones JE, Mendes L, Rudd MA, Russo G, Loscalzo J, Zhang YY. Serial noninvasive assessment of progressive pulmonary hypertension in a rat model. Am J Physiol Heart Circ Physiol. 2002; 283: H364-H371.
9. Tournoux F, Thibault H, Petersen B, Raher MJ, Halpern E, Picard MH, Scherrer-Crosbie M. Validation of a non-invasive method to measure cardiac output in mice [abstract]. Eur Heart J. 2008; S1: 4623.
10. Weyman AE, Dillon JC, Feigenbaum H, Chang S. Echocardiographic patterns of pulmonic valve motion with pulmonary hypertension. Circulation. 1974; 50: 905-910.
11. Beard JT II, Newman JH, Loyd JE, Byrd BF III. Doppler estimation of changes in pulmonary artery pressure during hypoxic breathing. J Am Soc Echocardiogr. 1991; 4: 121-130.
12. Dabestani A, Mahan G, Gardin JM, Takenaka K, Burn C, Allfie A, Henry WL. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol. 1987; 59: 662-668.
13. Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation. 1983; 68: 302-309.
14. Isobe M, Yazaki Y, Takaku F, Koizumi K, Hara K, Tsuneyoshi H, Yamaguchi T, Machii K. Prediction of pulmonary arterial pressure in adults by pulsed Doppler echocardiography. Am J Cardiol. 1986; 57: 316-321.
15. Martin-Duran R, Larman M, Trugeda A, Vazquez de Prada JA, Ruano J, Torres A, Figueroa A, Pajaron A, Nistal F. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol. 1986; 57: 859-863.
16. Deb B, Bradford K, Pearl RG. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med. 2000; 28: 795-799.
17. Evgenov OV, Ichinose F, Evgenov NV, Gnoth MJ, Falkowski GE, Chang Y, Bloch KD, Zapol WM. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation. 2004; 110: 2253-2259.
18. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA. Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000; 22: 535-542.
19. Shine B. Use of routine clinical laboratory data to define reference intervals. Ann Clin Biochem. 2008; 45: 467-475.
20. Kosturakis D, Goldberg SJ, Allen HD, Loeber C. Doppler echocardio-graphic prediction of pulmonary arterial hypertension in congenital heart disease. Am J Cardiol. 1984; 53: 1110-1115.
21. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987; 9: 549-554.
22. Grignola JC, Bia D, Gines F, Armentano RL. Acute pulmonary hypertension: protective role of vascular smooth muscle activation. Rev Esp Cardiol. 2003; 56: 1077-1084.
23. Leighton RF, Weissler AM, Weinstein PB, Wooley CF. Right and left ventricular systolic time intervals: effects of heart rate, respiration and atrial pacing. Am J Cardiol. 1971; 27: 66-72.
24. Kligfield P, Okin P. Effect of ventricular function on left ventricular ejection time in aortic stenosis. Br Heart J. 1979; 42: 438-441.
25. Haddad F, Zamanian R, Beraud AS, Schnittger I, Feinstein J, Peterson T, Yang P, Doyle R, Rosenthal D. A novel non-invasive method of esti-mating pulmonary vascular resistance in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr. 2009; 22: 523-529.
26. Roth DM, Swaney JS, Dalton ND, Gilpin EA, Ross J Jr. Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol. 2002; 282: H2134-H2140.
27. Verdejo HE, Castro PF, Concepcion R, Ferrada MA, Alfaro MA, Alcaino ME, Deck CC, Bourge RC. Comparison of a radiofrequency-based wireless pressure sensor to Swan-Ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. J Am Coll Cardiol. 2007; 50: 2375-2382.